These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27994502)

  • 1. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
    Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
    Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
    Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
    Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.
    Qin YR; Tang H; Xie F; Liu H; Zhu Y; Ai J; Chen L; Li Y; Kwong DL; Fu L; Guan XY
    Clin Cancer Res; 2011 Jan; 17(1):46-55. PubMed ID: 21084391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of FAM3C in esophageal squamous cell carcinoma.
    Zhu YH; Zhang B; Li M; Huang P; Sun J; Fu J; Guan XY
    Diagn Pathol; 2015 Oct; 10():192. PubMed ID: 26498278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
    Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
    Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
    Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of δ-catenin in esophageal squamous cell carcinoma and its correlations with prognosis of patients.
    Zhang JY; Bai CY; Bai YQ; Zhang JY; Wu ZY; Wang SH; Xu XE; Wu JY; Zhu Y; Rui Y; Li EM; Xu LY
    Hum Pathol; 2014 Oct; 45(10):2014-22. PubMed ID: 25090917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.
    Hao CL; Li Y; Yang HX; Luo RZ; Zhang Y; Zhang MF; Cheng YF; Wang X
    Int J Clin Exp Pathol; 2014; 7(7):4213-21. PubMed ID: 25120801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.
    Kumakura Y; Rokudai S; Iijima M; Altan B; Yoshida T; Bao H; Yokobori T; Sakai M; Sohda M; Miyazaki T; Nishiyama M; Kuwano H
    Cancer Sci; 2017 Nov; 108(11):2149-2155. PubMed ID: 28892579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
    Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
    Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
    Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
    Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of uc.189 in patients with esophageal squamous cell carcinoma and its clinicopathologic value.
    Guo Y; Wang C; Miao X; Chen S; Qian Y; Li G; Jiang Y
    Pathol Res Pract; 2017 Nov; 213(11):1400-1403. PubMed ID: 28941722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.